BackMyriad Genetics Overview

Myriad Genetics Cost of Revenue

Cost of Revenue analysis for MYGN.

Quarterly Cost of Revenue

$62.80M
1.78% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$249.00M
0.12% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)